Midterm Outcomes of the BeGraft and BeGraft Plus Bridging Covered Stents for Fenestrated and Branched Endovascular Aneurysm Repair

The aim of this study was to report outcomes of the BeGraft and BeGraft Plus as bridging covered stents in fenestrated and branched endovascular aneurysm repair (FB-EVAR). Patients treated and followed in two institutions receiving at least one BeGraft or BeGraft Plus as bridging covered stent betwe...

Full description

Saved in:
Bibliographic Details
Published in:European journal of vascular and endovascular surgery 2024-11
Main Authors: Katsargyris, Athanasios, Hasemaki, Natasha, Abu Jiries, Melad, Klonaris, Chris, Verhoeven, Eric L.G., Marques de Marino, Pablo
Format: Article
Language:English
Subjects:
Bridging stent
Instability
Juxtarenal
Patency
Suprarenal
Thoraco-abdominal
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of this study was to report outcomes of the BeGraft and BeGraft Plus as bridging covered stents in fenestrated and branched endovascular aneurysm repair (FB-EVAR). Patients treated and followed in two institutions receiving at least one BeGraft or BeGraft Plus as bridging covered stent between January 2018 and July 2023 were included. A total of 765 target vessels (TVs) in 281 patients were aimed to be bridged with the BeGraft or BeGraft Plus. Target vessel technical success was 99.5% (761/765). Estimated TV patency at one and two years was 98.5 ± 0.5% and 96.7 ± 0.9%, respectively, with no difference between fenestrations and branches. Estimated freedom from TV related endoleak at one and two years was 98.5 ± 0.5% and 97.9 ± 0.6%, respectively. Estimated freedom from endoleak at two years was lower for TVs targeted with branches compared with TVs targeted with fenestrations (94.2 ± 1.9% vs. 99.7 ± 0.3%, respectively; p
ISSN:1078-5884
1532-2165
1532-2165
DOI:10.1016/j.ejvs.2024.10.046